We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Inexpensive DNA Coated Electrode Paves Way for Disposable Diagnostics

By LabMedica International staff writers
Posted on 03 Jul 2025

Many people around the world still lack access to affordable, easy-to-use diagnostics for diseases like cancer, HIV, and influenza. More...

Conventional sensors, while accurate, often rely on expensive equipment or require refrigeration, limiting their use in low-resource or non-clinical settings. One major limitation with DNA-based electrochemical sensors is that the DNA coating breaks down quickly, requiring the sensors to be prepared immediately before use and stored under tightly controlled conditions. This significantly restricts their practicality, especially in rugged or remote environments. Researchers have now developed a new solution that stabilizes these sensors for longer shelf life and better usability, even at high temperatures, without compromising diagnostic accuracy.

Developed by a team at MIT (Cambridge, MA, USA), the new electrochemical sensor uses a gold leaf electrode coated with DNA and stabilized with polyvinyl alcohol (PVA), a low-cost polymer. The sensors are based on CRISPR-associated enzyme Cas12, which is paired with guide RNA to detect specific DNA or RNA targets. When the target—such as a cancerous gene—is present, the enzyme activates and nonspecifically cleaves the DNA coating the electrode, thereby altering the electrical signal. This signal can be measured using a potentiostat, similar to the technology in glucose meters. The PVA coating acts like a protective tarp, preventing oxidative damage and preserving the thiol-gold bond that secures the DNA. Once dried, the PVA forms a barrier that protects the DNA until it’s ready to be rinsed off for use. These sensors, costing only around 50 cents each, can be laminated onto plastic and are intended for point-of-use applications, including at-home testing. Earlier versions were already capable of detecting HIV and HPV; the latest design further enhances usability by increasing shelf-life and simplifying deployment.

In the study published in ACS Sensors, the researchers demonstrated that the PVA coating preserved sensor stability for up to two months, even at temperatures as high as 150°F. After storage, the sensors successfully detected PCA3, a prostate cancer gene found in urine, and the method can be adapted for saliva, nasal swabs, and other sample types. The team now plans to expand testing with real-world patient samples across multiple diseases. With support from MIT’s delta v venture accelerator, the group is exploring commercialization opportunities to ship the stabilized sensors to low-resource regions without requiring refrigeration. They are also working on adapting the platform to respond to emerging infectious diseases and scale distribution for widespread use.

“Our goal is to continue to test with patient samples against different diseases in real-world environments,” said Ariel Furst, the Paul M. Cook Career Development Assistant Professor of Chemical Engineering at MIT and senior author of the study. “Our limitation before was that we had to make the sensors on site, but now that we can protect them, we can ship them. We don’t have to use refrigeration. That allows us to access a lot more rugged or non-ideal environments for testing.”

Related Links:
MIT


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Clinical Chemistry

view channel
Image: The steps involved in the electric field-induced capture and release (EFIRM) assay (Photo courtesy of UCLA School of Dentistry)

Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation

Early detection of cancer and other serious diseases is crucial for effective treatment and improved outcomes, yet current diagnostic methods often involve invasive procedures and complex sample preparation.... Read more

Molecular Diagnostics

view channel
Image: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is FDA-cleared for use in diagnosing Alzheimer’s (Photo courtesy of Fujirebio)

First FDA Cleared Blood Test for Alzheimer’s Diagnosis Marks Turning Point in Early Detection

Alzheimer’s disease is a progressive form of dementia that affects memory, cognition, and behavior, eventually interfering with daily activities. Early and accurate diagnosis is essential to improving... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.